# The EPOCH Study (Eplerenone on Top of ACE Inhibition in Chronic Kidney Disease Patients With Hypertension)

> **NCT01832558** · NA · UNKNOWN · sponsor: **Medical University of Vienna** · enrollment: 24 (estimated)

## Conditions studied

- CKD II-III

## Interventions

- **DRUG:** Eplerenone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01832558
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-11
- **Primary completion:** 2020-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2020-06-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01832558

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01832558, "The EPOCH Study (Eplerenone on Top of ACE Inhibition in Chronic Kidney Disease Patients With Hypertension)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01832558. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*